Publication of 2021 AGM Notice

By

Regulatory News | 30 Mar, 2021

Updated : 16:21

RNS Number : 0161U
GlaxoSmithKline PLC
30 March 2021
 

GlaxoSmithKline plc

(the 'Company')

 

Publication of Notice of Annual General Meeting 2021

 

The Company has today published on its website (www.gsk.com/en-gb/investors/shareholder-information/annual-general-meeting/) the Notice of Annual General Meeting ('AGM') 2021 (the '2021 AGM Notice') which will be distributed to shareholders shortly.

 

The AGM will be broadcast live and all shareholders are invited to join electronically. UK Government COVID-19 restrictions mean that shareholders will unfortunately not be permitted to physically attend the AGM this year. 

The Company's AGM is to be held at 2.30pm on Wednesday, 5 May 2021 at the Company's registered office at 980 Great West Road, Brentford, Middlesex, TW8 9GS.

We are maximising the use of existing technology to offer shareholders a range of ways to participate in the AGM given that they cannot attend in person. Full details of how to join the meeting are being sent to shareholders directly and are contained in the 2021 AGM Notice and AGM Guide.

In compliance with Listing Rule 9.6.1R of the UK Financial Conduct Authority, the 2021 AGM Notice will be submitted to the UK Listing Authority and will, in due course, be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

V A Whyte

Company Secretary

 

30 March 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOAEASDEDFKFEFA

Last news